SEI Investments’s Abivax ABVX Stock Holding History

SEI Investments’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.1M	Buy	132,736 +40,560	+44%	+$4.89M	0.01%	980
2026 Q2	$12.3M	Sell	92,176 -2,044	-2%	-$231K	0.01%	1034
2026 Q1	$10.5M	Buy	94,220 +7,067	+8%	+$836K	0.01%	1122
2025 Q4	$11.7M	Buy	87,153 +20,428	+31%	+$2.23M	0.01%	991
2025 Q3	$5.66M	Buy	+66,725	New	+$4.09M	0.01%	1256

Other funds holding ABVX

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Creek Drive Management Group San Francisco, California $368M AUM 23.05% 1-Year Est. Return

Western Standard LLC Los Angeles, California $424M AUM 17.4% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

SEI Investments's ABVX Position: Q3 2026 in Review

SEI Investments increased its Abivax (ABVX) stake by 44% in Q3 2026, buying an estimated $4.89M and bringing the position to 132,736 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #980.

SEI Investments first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

SEI Investments held 132,736 shares of Abivax worth $13.1M as of Q3 2026.
SEI Investments bought 40,560 Abivax shares in Q3 2026, an estimated $4.89M.
Abivax made up 0.01% of SEI Investments's portfolio in Q3 2026, its #980 holding.
SEI Investments first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
122 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.